DHR · News · 20261104N

Glycomics Market Growth

DANAHER CORP /DE/ · 2026-11-04 · Importance 23 · Surprise 22

A third-party industry report estimates the global glycomics and glycobiology market was valued at US$1.8 billion in 2025 and projects it will reach US$4.5 billion by 2032, a 13.7% CAGR. The report identifies personalized medicine, biologic drug development, disease-biomarker research, and glycan-analysis innovation as growth drivers. Danaher is listed among companies competing in the market, alongside Agilent, Bruker, Merck, and Thermo Fisher.